Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Other Accumulated Expenses (2014 - 2018)

Updated

Cartesian Therapeutics (RNAC) reported Other Accumulated Expenses of $831,000 for Q2 2016.

Analysis

Cartesian Therapeutics (RNAC) Other Accumulated Expenses (2014 - 2018) Analysis & Trends

At the end of FY2015, Cartesian Therapeutics posted Other Accumulated Expenses of $223,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 35.14 Mn
Sep 30, 2018 34.63 Mn
Jun 30, 2018 13.89 Mn
Mar 31, 2018 11.81 Mn
Dec 31, 2017 35.14 Mn
Jun 30, 2016 831,000.00
Dec 31, 2015 223,000.00
Dec 31, 2014 35.14 Mn
API Access

Cartesian Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RNAC&period=max&api_key=YOUR_API_KEY